About PolpharmaWe are the largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market. We actively operate in the markets of Central and Eastern Europe, the Caucasus and Central Asia.
Sustainable development/ESG“We help people live healthy lives in a healthy world”. This is our mission, which reflects Polpharma’s priorities. We provide patients with high-quality, effective, safe and accessible products while operating responsibly in the society, the environment and with respect to key stakeholders.
CareerPolpharma's development is possible only thanks to the commitment of our employees as well as the involvement of students and graduates in various business areas.
Other PRICE INQUIRY No. NUSI 135/PR144016/202613 April 2026In connection with the implementation of the project entitled “Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological… read more
Other PRICE INQUIRY No. NUSI/136/PR146317/2026 – being conducted as a market assessment study 13 March 2026In connection with the implementation of the project titled “Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological… read more
Other PRICE INQUIRY No. RIA/10/PR145304/2026 – being conducted as a market assessment study 26 February 2026In connection with the implementation of the project titled “Development and development of an innovative solution – a complex, three-component medicinal product, aimed at the… read more
Other PRICE INQUIRY No. NUSI/129/PR123833/2025 – being conducted as a market assessment study20 October 2025In connection with the implementation of the project titled “Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological… read more
Other PRICE INQUIRY No. NUSI/128A/PR123833/2025 – being conducted as a market assessment study 25 September 2025In connection with the implementation of the project titled “Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological… read more
